Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (ANDA) filed by NorthStar Rx LLC.
-
FDA approval · 2014-08-15FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approves Lupin Pharmaceuticals' metoclopramide hydrochloride for original application, making a generic antiemetic and prokinetic agent …
-
FDA approval · 2014-06-05FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Hydroxyzine Hydrochloride from Teva Pharmaceuticals USA, Inc., granting regulatory clearance…
-
FDA approval · 2014-01-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., indicating an additional regulato…
-
FDA approval · 2013-04-19FDA Approved: METOCLOPRAMIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA's original application for metoclopramide hydrochloride, a generic version of metoclopramide.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-30FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling und…
-
FDA approval · 2012-09-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., completing regulatory action for …
-
CLINICAL_TRIALS research · 2012-08-20Clinical Trial Update: Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension [NA]
A clinical trial update from Seoul National University Hospital evaluating different 5-HT3 receptor antagonists at various doses for prevent…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition [Phase 1]
This update reports the completion of a Phase 1 bioequivalence study of Ondansetron 8 mg tablets under fasting conditions.
-
FDA approval · 2012-03-14FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Chartwell Governmental & Specialty RX, LLC., signaling an …
-
FDA approval · 2012-03-08FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited.
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, signaling an approved update to the…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer [NA]
Clinical trial evaluating hypnosis to reduce pain and other side effects in women undergoing breast cancer surgery has completed.
-
FDA label_change · 2011-02-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for metoclopramide, resulting in changes to the drug's labeling.
-
FDA approval · 2010-12-13FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original application for generic promethazine hydrochloride, enabling the sale of a generic antihis…
-
FDA approval · 2010-12-03FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2010-11-18FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for REGLAN (metoclopramide hydrochloride) from ANI Pharmaceuticals, representing an approved regulat…
-
FDA approval · 2010-06-04FDA Approved: MECLIZINE HYDROCHLORIDE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for meclizine hydrochloride from Jubilant Cadista Pharmaceuticals Inc., enabling a generic version of …
-
FDA approval · 2010-06-03FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Parenteral Medicines, Inc., updating the product's approval status as p…
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals’ supplemental application for metoclopramide, updating the regulatory status of this generic drug.
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for metoclopramide (generic).
-
FDA approval · 2009-08-18FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA granted a supplemental approval for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2009-07-15FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approves a supplemental application for Prochlorperazine Maleate from Jubilant Cadista Pharmaceuticals Inc., granting approval for a gen…
-
FDA approval · 2009-06-30FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for metoclopramide hydrochloride (generic), filed by Chartwell Governmental & Specialty RX, LLC., as…
-
FDA approval · 2009-06-30FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Reglan (metoclopramide hydrochloride) submitted by ANI Pharmaceuticals, Inc. for NDA 017854.